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Synopsis Recent developments of the Phenix software package are described in the context of 
macromolecular structure determination with X-rays, neutrons and electrons. 
Abstract Diffraction (X-ray, neutron, electron) and electron cryo-microscopy are powerful 
methods to determine three-dimensional macromolecular structures that are required to understand 
biological processes and to develop new therapeutics against diseases. The overall structure solution 
workflow is similar for these techniques, but nuances exist because the properties of the reduced 
experimental data are different. Software tools for structure determination should therefore be tailored 
for each method. Phenix is a comprehensive software package for macromolecular structure 
determination that handles data from any of these techniques. Tasks performed with Phenix include 
data quality assessment, map improvement, model building, the validation/rebuilding/refinement 
cycle and deposition. Each tool caters to the type of experimental data. The design of Phenix 
emphasizes automation of procedures where possible to minimize repetitive and time-consuming 
manual tasks, while default parameters are chosen to encourage best practice. A graphical user 
interface provides access to many command-line features of Phenix and streamlines the transition 
between programs, project tracking and re-running of previous tasks. 
Keywords: Phenix, Automation, Macromolecular crystallography, Cryo-EM, X-ray, Neutron, 
Diffraction, Python, cctbx 
 
1. Introduction 
Macromolecules are essential for biological processes within organisms engendering the need to 
understand their behavior to explain the fundamentals of life. The function of macromolecules 
correlates with their three-dimensional structure, i.e. how the atoms of the molecule are arranged in 
space and how they move over time. Two major methods to obtain macromolecular structures are 
diffraction (usually using X-rays, but also neutrons or electrons) and electron cryo-microscopy (cryo-
EM1) (Fig. 1), both of which are handled by Phenix. The following subsections describe some 
concepts underpinning each method for the benefit of readers who are not experts in each of these 
areas. 
1.1. X-ray diffraction 
X-ray diffraction relies on the interaction of X-rays with the electron cloud of atoms in a crystal. As 
the atomic core electron density dominates the electron density distribution, major peaks equate to 
atomic positions and can be used to determine the structure. An exception is the hydrogen atom 
                                                   
1 A consensus for the name is not yet established, both the terms “cryo-electron microscopy” or 
“electron cryo-microscopy” can be found in the literature (Jensen, 2010). 
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because it possesses only one valence electron whose distribution is shifted towards its covalent bond 
partner. The electron density in the unit cell is related to the Fourier transform of the amplitude and 
phase of the scattered X-rays. As only intensities of the waves can be measured, the phase information 
is lost and has to be inferred by various methods (section 4.1). 
Of the models deposited in the Protein Data Bank (PDB) (Bernstein et al., 1977; Burley et al., 2019), 
89 % originate from X-ray crystallography. Since the first protein structures were determined in the 
1950’s (Kendrew et al., 1958; Perutz et al., 1960), the method has experienced many methodological 
and technological developments and is now considered quite mature (Wlodawer et al., 2013). 
Nevertheless, structures determined at low resolution (for example, worse than 3 Å) remain 
challenging and could benefit from some of the new developments for cryo-EM that target similar 
resolution ranges. 
1.2. Neutron diffraction 
Neutron diffraction, which relies on the same formalism as X-ray diffraction, is based on the 
interaction of neutrons with atomic nuclei and therefore yields actual atomic positions directly. As the 
neutron scattering cross section varies by element (or isotope) in a nonlinear fashion, the scattering 
lengths of light atoms such as hydrogen and deuterium atoms (D) are similar to those of the heavier 
atoms (C, O, N). It is therefore possible to locate H (or D) atoms and deduce protonation states; this 
knowledge helps in understanding catalytic mechanisms and ligand binding (Yamaguchi et al., 2009; 
Bryan et al., 2013; Knihtila et al., 2015). Furthermore, the neutron scattering length can be positive or 
negative (it is always positive for X-rays). For example, H has a negative scattering length, whose 
magnitude is about half of the scattering length of carbon. The nuclear scattering length density can 
therefore cancel out for groups such as CH2, which occur frequently in macromolecules. To avoid 
negative scattering of hydrogen atoms, hydrogen can be partially or fully exchanged with deuterium, 
by soaking the crystal in deuterated buffer solutions or by performing protein expression in fully 
deuterated reagents, respectively. 
The number of structures determined by neutron crystallography (0.1 % of models deposited in the 
PDB) is small compared to the number of X-ray structures (89 %). Neutron diffraction is not used to 
solve the structure of a macromolecule de novo as it requires considerable effort to prepare deuterated 
crystals suitable for the experiment. Instead, neutron diffraction provides complementary information 
because it enables locating hydrogen or deuterium atoms.  
1.3. Cryo-EM 
Cryo-EM relies on the interaction of electrons with the electrostatic field of the atoms in the sample. 
The method comprises many techniques, such as electron tomography, electron single-particle 
microscopy or electron crystallography. Single-particle analysis is a commonly used variant that 
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combines 2D projection images of macromolecules into a 3D reconstruction (electrostatic potential 
map or cryo-EM map). This is in contrast to diffraction experiments, where phase information is lost 
(in the absence of experimental phases, electron density maps thus have to be calculated using a 
model). While being visually similar to electron density maps from X-ray diffraction, a cryo-EM map 
exhibits some differences, such as negative peaks from negatively charged nucleic acids (Wang & 
Moore, 2017). Furthermore, the reconstruction process and motion or heterogeneity of the sample can 
lead to blurring of cryo-EM maps; high-resolution details can be revealed by operations such as map-
sharpening (section 4.2). 
Cryo-EM was traditionally employed to investigate large protein and nucleic acid complexes, 
filaments and viruses but was often limited to resolutions worse than 5 Å. Technological advances, 
such as the development of direct electron detectors (Li et al., 2013) and improvements in image 
processing  (Bai et al., 2015) have transformed the method, leading to greatly improved resolution of 
cryo-EM maps. More recently, 3D reconstructions routinely attain resolutions significantly better than 
4 Å, allowing for atomic model interpretation and solving structures de novo. Cryo-EM has thus 
become another principal method of macromolecular structure determination (2 % of models 
deposited in the PDB). For large molecules and structures determined at low resolution, annual cryo-
EM model depositions now outnumber X-ray models (Figs. 2 and 3). 
1.4. Other techniques 
Another method to determine macromolecular structures is NMR (Nuclear magnetic resonance, 9 % 
of models deposited in the PDB), which uses quantum properties of atomic nuclei. Phenix does not 
have tools for structure determination with NMR data, so it is not addressed here. 
Electron diffraction on nearly single-layer crystals is an emerging technique to determine high-
resolution structures of macromolecules. It accounts for a slightly smaller number of models in the 
PDB than neutron diffraction. 
1.5. Phenix 
Phenix (Adams et al., 2002, 2010) is a software suite that uses reduced data from X-ray diffraction, 
electron diffraction, neutron diffraction or cryo-EM to determine macromolecular structures. Each 
method has a different approach to derive structural information, with Phenix offering specific tools to 
address the unique properties of the experimental data. Emphasis is put on the automation of all 
procedures to avoid burdening the user with repetitive, time-consuming and often error-prone tasks. 
Another important feature is the user-friendly design making the program accessible to novice users 
while keeping it flexible for experts. New tools are regularly developed or enhanced to improve the 
structure solution workflow. For example, a series of programs, which focuses on the analysis of 
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cryo-EM maps and models, was recently created to answer the emerging needs of the cryo-EM 
community.  
This paper describes the structure determination process of three methods (X-ray diffraction, neutron 
diffraction and cryo-EM), summarizes major tools and reports recent developments in Phenix. 
2. Steps in the structure solution process 
Figure 4 shows the steps of the structure solution process for X-ray/neutron crystallography and cryo-
EM. Due to the different nature of the interactions, there are nuances for each structure determination 
method (Figs. 5 and 6), but the overall procedure to obtain a molecular model is similar. The first step 
consists of analyzing the derived experimental data to detect any anomalies that can complicate or 
even prevent structure determination (section 3). The second and third steps are to obtain the best 
possible map (section 4) so that a model can be built (section 5). The fourth step focuses on iteratively 
improving the model by cycles of local rebuilding, refinement and validation (sections 6 and 7). The 
following sections elaborate on the steps and explain similarities and differences for X-ray/neutron 
crystallographic and cryo-EM data. Phenix tools that perform the corresponding steps are described.   
3. Data quality assessment 
Data quality should be analyzed carefully because unusual features can thwart structure solution. If 
the data have anomalies, it is not guaranteed that they can be addressed at later stages, in which case it 
might be necessary to perform new experiments or re-analyze the raw data. 
3.1. Crystallography 
3.1.1. Xtriage 
Macromolecular crystals are prone to pathologies and rarely achieve perfect order, as the molecules 
interact weakly with each other. For example, a crystal is called “twinned” if two or more crystals 
(domains) are intergrown in such a way that their orientations are related by a specific geometrical 
operation (twin operation) (Hahn & Klapper, 2006). The overlap of diffraction spots adds noise to the 
measurements and reduces the information content of the data. Translational non-crystallographic 
symmetry (tNCS) is another pathology that complicates structure determination. This arises when 
more than one copy of a molecule or assembly is found in a similar orientation in the asymmetric unit 
of the crystal. Interference effects between diffraction from the copies lead to an overall modulation 
of the intensities in the diffraction pattern. 
The program Xtriage (phenix.xtriage) identifies twinning, tNCS and other unusual features of 
diffraction data (Zwart et al., 2005). To detect twinning, the tool examines amplitude and intensity 
ratios, 〈|𝐸$ − 1|〉 values, the L-statistic (Padilla & Yeates, 2003) and N(Z) plots (Howells et al., 
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1950). The twin fraction is estimated by interpreting the Britton plot2 (Britton, 1972) and performing 
the H-test (Yeates, 1997). Xtriage reveals tNCS using the native Patterson function and uses database-
derived Wilson plots to find anomalies in the mean intensity. The tool also analyses reflection 
merging statistics to detect if the input data symmetry is too low and systematic absences to identify 
screw axes. A warning is issued if ice rings are detected. Apart from identifying pathologies, Xtriage 
also reports data quality indicators, such as the signal-to-noise ratio and data completeness. 
Furthermore, the tool estimates anomalous signal strength based on the fraction of statistically 
significant Bijvoet differences (Zwart, 2005) and the overall anisotropic scale factor using the 
likelihood formalism described by Popov & Bourenkov (2003). 
3.1.2. Planning and assessing a SAD experiment 
Before conducting a single-wavelength anomalous diffraction (SAD) diffraction experiment, it is 
useful to assess its chances of success. “Plan SAD experiment” is a new tool for estimating the 
anomalous signal from a SAD experiment with a particular anomalous scatterer and data quality, and 
for predicting whether this signal would be sufficient to solve the structure (Terwilliger et al., 
2016a,b). The tool provides a summary of the anomalous signal required and what can be expected if 
the data can be measured with the suggested overall signal-to-noise ratio (I/σ). Once data have been 
collected and then scaled with the “Scale and Merge Data” tool, the “Anomalous Signal” tool 
estimates the amount of signal that has actually been achieved and predicts whether or not this will be 
sufficient to solve the structure. 
3.2. Cryo-EM: Mtriage 
The sample for a cryo-EM experiment is not crystalline, so many of the problems discussed in the 
previous section (3.1.1) are not relevant. However, the quality of the reconstruction and therefore the 
interpretability of a cryo-EM map can deteriorate from many causes, such as structural heterogeneity, 
radiation damage and beam induced sample movement. The information content of a cryo-EM map is 
typically expressed by the resolution. While the same term (“resolution”) is used in crystallography to 
describe data quality, its meaning differs: the resolution of a crystallographic data set depends on the 
largest angle to which diffracted beams were measured or, equivalently, the shortest distance between 
reciprocal lattice planes (McPherson, 2009). The overall resolution dFSC of a cryo-EM map is usually 
defined as the maximum spatial frequency at which the information content of the map is reliable 
(Penczek, 2010). The value is obtained by analyzing the Fourier shell correlation (FSC) for two cryo-
EM half-maps binned in resolution shells (van Heel & Harauz, 1986). If the macromolecule is 
structurally heterogeneous (e.g. flexible regions in the macromolecule), a single value for the 
                                                   
2 Number of negative intensities after detwinning as a function of the twin fraction. 
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resolution is most likely inadequate. A “local resolution” is thus assigned to different map regions 
(Cardone et al., 2013; Kucukelbir et al., 2014).   
In Phenix, the resolution of cryo-EM maps can be estimated with the newly developed tool Mtriage 
(phenix.mtriage) (Afonine, Klaholz et al., 2018) using several different approaches, some of which 
fundamentally differ from dFSC. The tool also summarizes map statistics. As the map resolution strongly 
influences decisions made in subsequent steps, it is important to get a reliable estimate.  
3.3. Common map tools  
Several new tools are available to analyze cryo-EM maps (or any map). In the context of molecular 
densities, a map is a 3D grid of density values. The map has an origin and a gridding (the distance 
between neighboring grid points). A map typically extends only over grid points where the values are 
non-zero (and a buffer), but it is possible that a majority of map points is zero or very small. 
Especially for cryo-EM, the molecules can have symmetry (such as viruses) and the map will have the 
same symmetry. The following tools analyze maps and perform some basic operations: 
– “Show map info” (phenix.show_map_info) lists properties of a map, such as origin, grid points, unit 
cell and map size.  
– “Map box” (phenix.map_box) cuts out a box from a large map. 
– Some molecules, such as viruses, can have high internal symmetry. It can thus be beneficial to 
reduce the map to the repeating unit. “Map symmetry” (phenix.symmetry_from_map) finds such 
symmetries and “Map box” can extract the unique part of the map. 
– The tool “Combine focused maps” (phenix.combine_focused_maps) creates a weighted composite 
map from a set of locally focused maps and associated models, where each part of each map is 
weighted by its correlation with the corresponding model.  
4. Optimizing maps 
4.1. X-ray 
To calculate maps, the phase information is required. As phases are lost in the diffraction experiment, 
they have to be recovered by additional experiments or by computational procedures. In Phenix, 
phases can be determined by experimental phasing or by molecular replacement (Adams, Afonine et 
al., 2009). Once an initial set of phases is known, they can be improved by optimizing electron 
density maps or by optimizing an atomic model from which phases are calculated. 
4.1.1. Experimental phasing 
Experimental phasing relies on the properties of a few special atoms in the macromolecule. The 
special properties can be a large number of electrons, anomalous scattering or a combination of both 
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(reviewed by Dauter & Dauter, 2017).  Phasing is then performed in two steps: 1) The properties are 
exploited to determine the location of the special atoms (substructure). 2) Knowledge of the 
substructure in one or more crystals is used to deduce phase information for the entire 
macromolecule.  
AutoSol (phenix.autosol) is a comprehensive, automatic tool that performs experimental phasing with 
the MAD, MIR, SIR or SAD methods3 (Terwilliger et al., 2009). The program locates the 
substructure, estimates phases, performs density modification, identifies non-crystallographic 
symmetry (NCS), builds and refines a preliminary model. To carry out the tasks, AutoSol uses the 
Phenix tools HySS (Hybrid Substructure Search) (Grosse-Kunstleve & Adams, 2003; Bunkoczi et al., 
2013), SOLVE (Terwilliger & Berendzen, 1999), Phaser (McCoy et al., 2007), RESOLVE 
(Terwilliger, 2002), Xtriage and phenix.refine (Afonine et al., 2012). 
4.1.2. Molecular replacement 
Molecular replacement (MR) is used to solve structures when a structurally similar model 
(homologue) is available (Hoppe, 1957; Rossmann, 1972; Blow et al., 2012). Success in MR 
calculations is determined by how much signal can be extracted from the data using a particular 
model. This depends on a combination of model quality and completeness, resolution of the data and 
the number of diffraction observations (Oeffner et al., 2018). For typical cases involving crystals of 
medium-sized proteins diffracting to moderate resolution, the sequence identity between the molecule 
and the homologue should be greater than 25-30 % and the r.m.s. deviation between Cα atoms should 
be less than 2.0 Å (Taylor, 2010). The search model can be enhanced by trimming off parts of the 
model that are unlikely to be preserved in the target structure, using Sculptor (phenix.sculptor) 
(Bunkóczi & Read, 2011). The MR method consists of determining the orientation and position that 
places each copy of the homologue in the unit cell containing the unknown structure, judged by 
matching the calculated structure factors to the observed ones. An initial electron density map is then 
calculated with the phases from the homologue and the observed structure factors (Evans & McCoy, 
2008). 
Phaser (phenix.phaser) applies maximum-likelihood principles (Bayesian probabilities) to crystal 
structure solution by MR, by single-wavelength anomalous diffraction (SAD) or by a combination of 
both (MR-SAD) (McCoy et al., 2007). In common with most MR algorithms, it divides the six-
dimensional search problem for each copy into a three-dimensional rotation search followed by a 
three-dimensional translation search. The use of maximum-likelihood accounts for the effects of 
model imperfections and measurement error in the diffraction observations. In addition, likelihood 
provides a framework for the use of ensemble models created with Ensembler (phenix.ensembler) and 
                                                   
3 MAD = multiple-wavelength anomalous diffraction, MIR = multiple isomorphous replacement, SIR 
= single isomorphous replacement 
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for exploiting the placement of one copy to increase the signal of the search for another copy (McCoy 
et al., 2007). 
4.1.3. Density modification 
As initial phases are often quite inaccurate, they need to be improved by exploiting prior knowledge 
about electron density distributions in crystals (Podjarny et al., 1996). Examples of methods to 
improve phases are solvent flattening, histogram matching and, if NCS is present, non-
crystallographic symmetry averaging.  
Several Phenix programs carry out density modification: phenix.density_modification performs 
iterative phase improvement with RESOLVE (Terwilliger, 2000), including the use of NCS and 
electron-density distributions. phenix.multi_crystal_average improves phases iteratively and averages 
electron density, both within a crystal and between crystals. Phenix.ncs_average can be used to 
average the electron density for molecules related by NCS.  
4.2. Cryo-EM: map optimization 
In the crystallographic case map improvement is achieved by manipulation of phase information, with 
the diffraction intensities (or amplitudes) remaining unchanged4. In contrast, cryo-EM maps are 
improved by methods such as sharpening and blurring, that typically modify the amplitudes of Fourier 
coefficients, leaving the phases unchanged. Cryo-EM maps can appear smooth and lack a high level 
of detail (contrast) because high-resolution amplitudes of corresponding Fourier map coefficients 
decay from causes such as radiation damage, sample movement, sample heterogeneity and errors in 
the reconstruction procedure. However, sharpening can reveal the high resolution details concealed in 
a cryo-EM map (Rosenthal & Henderson, 2003; Fernández et al., 2008). 
The recently developed program “Autosharpen map” (phenix.auto_sharpen) performs map 
sharpening by optimizing the detail and connectivity of a cryo-EM map (Terwilliger, Sobolev et al., 
2018). 
5. Obtaining a model that fits the experimental data 
To determine the structure of a macromolecule, a model must be built that fits the experimental data. 
Cryo-EM maps contain phase information, but they often have low resolution (Fig. 7), which makes 
interpretation difficult. For both techniques, but especially in the case of cryo-EM, the molecules can 
be very large so that automated procedures are preferred over manual interpretation, wherever 
feasible. 
                                                   
4 Exceptions exist: for example, some procedures fill in missing reflections with hypothetically 
derived values (Sheldrick, 2008). 
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5.1. X-ray           
Automatic model building is performed after phasing because the models from MR or AutoSol might 
be too incomplete to carry out refinement immediately: MR models typically originate from a 
homologue model which has a different sequence and side-chain conformations; it is thus necessary to 
build a model according to the sequence of the target molecule. AutoSol includes a building step, but 
in order to optimize runtime, it creates a preliminary model that can be further improved.  
AutoBuild (phenix.autobuild) is an automated system for model rebuilding and completion 
(Terwilliger et al., 2008). AutoBuild uses RESOLVE, Xtriage and phenix.refine to build an atomic 
model, refine it and improve it with iterative density modification, refinement and model building.  
5.2. Cryo-EM 
To obtain a model that fits the cryo-EM map, the following procedures are available. 
5.2.1. Docking 
A docking procedure is used if the model or a part of the model is already known (Roseman, 2000) 
but is not yet placed into the map. For example, the cryo-EM map might show a molecular complex 
assembled from components available from other experiments (such as crystallography). These 
components are then docked in the cryo-EM map to obtain a model for the entire complex. 
The new tool “Dock in map” (phenix.dock_in_map) docks one or several models into a map 
(Terwilliger, 2018). The routine uses a convolution-based shape search to find a part of a map that is 
similar to the model. The shape search applies the following key elements: An initial search, focusing 
on the overall shape of the molecule, is performed at lower resolution, This initial search is done 
without rotation to optimize runtime;, it can supplemented optionally by matching the moments of 
inertia of the model and map. If the placement is satisfactory, it is optimized using real-space rigid-
body refinement with the full resolution of the map.   
5.2.2. Model building 
If the structure of the molecule or of its components is unknown, the model has to be built ab initio 
into the cryo-EM map. This task is challenging, because the molecules are typically very large, chain 
tracing is difficult at low resolution and effective resolution can be even lower in some regions. 
Manual interpretation of cryo-EM maps is therefore time-consuming and error-prone, so automatic 
procedures are desirable. 
The recent tool “Map to model” (phenix.map_to_model) interprets a cryo-EM map and builds an 
atomic model (Terwilliger, Adams et al., 2018). All steps are performed automatically: First, the map 
is sharpened with “Autosharpen map” (section 4.2). The unique parts of the structure are then 
identified by taking into account reconstruction symmetry. The procedure also identifies which parts 
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of the map correspond to protein or RNA/DNA. After atomic models have been generated, they are 
real-space refined using secondary structure restraints (section 6.1.3). To get optimal building results, 
the resolution of the map should be 4.5 Å or better. 
6. Refinement 
Models from the building or phasing steps are approximate and need to be improved; for example, 
side chains may not fit the density and water molecules and ligands are likely to be missing. 
Refinement is the process of improving the parameters of a model until the best fit is achieved 
between experimental and model-calculated data. The parameterization of an atomic model mainly 
depends on the data quality and the current stage of refinement. Generally, the parameterization is 
chosen such that a simpler model is used in the beginning (such as rigid-body) and a more complex 
model is used towards the end. The target function guides the refinement by linking the model 
parameters to the experimental data and by scoring model-vs-data fit. For reciprocal space refinement, 
the target function (T) is expressed through structure factors (or diffraction intensities). For real-space 
refinement, the target is formulated in terms of a map. In both cases, the process alternates automated 
refinement with validation and either manual or automated model corrections. 
6.1. Restraints  
Crystallographic and cryo-EM refinements need additional information because there are generally 
too many model parameters compared to the amount of experimental data (unless the resolution is 
better than ~1 Å). Restraints introduce information and modify the target function by creating 
relationships between independent parameters. Using the example of restrained bond lengths, the 
coordinates of the two atoms are independent while the restraint keeps their distance within a certain 
target value and imposes a penalty if it deviates too much. Other restraints are imposed typically on 
bond angles, dihedrals, planes, chirality and coupling of atomic displacement parameters (ADPs) 
between bonded or neighboring atoms (Evans, 2007). 
If restraints are used, the target function is a sum of an experimental-data component (Tdata) and a 
weighted restraints-based component (wrestraintsxTrestraints): 
T = Tdata + wrestraints x Trestraints  (1) 
6.1.1. Stereochemical restraints 
Proteins and nucleic acids (RNA and DNA) are composed of amino acids and nucleotides, 
respectively. The structures of these components are known from small-molecule crystallography 
with the assumption that they are similar when they assemble to form a macromolecule. For bond 
lengths and angles, Phenix makes use of the CCP4 monomer library restraints (Engh & Huber, 1991; 
Vagin & Murshudov, 2004; Vagin et al., 2004) in protein side chains and somewhat modified classic 
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values for nucleic acids (Clowney et al., 1996; Gelbin et al., 1996). Planarity, dihedral angles and 
chirality are also restrained. Recent additions to restraints used in Phenix are the Conformation 
Dependent Library (Berkholz et al., 2009; Moriarty et al., 2014, 2016), which restrains the protein 
main chain as a function of the backbone dihedral values. Ribose-pucker and base-type dependent 
dihedral restraints are available for RNA (Jain et al., 2015). Algorithms, as opposed to libraries, are 
also used to provide stereochemical restraints. Linking including metal and metal cluster coordination 
(Moriarty & Adams, 2019), covalent bonding of standard and non-standard carbohydrates and other 
specialized entity specific restraints can be performed automatically. 
6.1.2. Ligand restraints 
Ligands are small molecules bound covalently or noncovalently to a macromolecule. While ligands 
can be naturally present, they can be also artifacts from reagents used for sample preparation or they 
can be introduced to investigate binding properties. Ligands in a model need to be refined and 
therefore need restraints. Some ligands are very common, so that geometry restraints are available in 
dictionaries (Vagin et al., 2004; Moriarty & Adams, http://sourceforge.net/projects/geostd) which can 
be obtained and updated from a number of sources (Moriarty & Adams, 2019). Other ligands are rare 
or novel requiring restraints be generated on a case-by-case basis.  
Phenix has several tools for generating and handling ligand restraints. eLBOW (phenix.elbow) 
automatically generates geometry restraints for novel ligands or improves restraints for standard 
ligands (Moriarty et al., 2009). ReadySet (phenix.ready_set) prepares a model for refinement by 
generating all necessary ligand restraints with eLBOW and by updating the model file to reflect atom 
name changes from the new restraints. The tool REEL includes a 3D view of the ligand and a tabular 
view of the restraints, so that target values and standard deviations can be easily edited (Moriarty et 
al., 2017). 
6.1.3. Other restraints 
Several other types of restraints are available in Phenix tools: 
– Secondary structure restraints: When data resolution is low, secondary structure elements (helices, 
sheets in proteins, base pairs and stacking pairs in nucleic acids) might not correctly maintain their 
conformation; for example a helix can lose its regular arrangement. Restraining the hydrogen bonds in 
the secondary structure element can help to maintain the regular structure (Headd et al., 2012). 
– Ramachandran plot restraints: The backbone dihedral angles can be restrained to stay in the allowed 
regions of the Ramachandran plot (Oldfield, 2001; Emsley et al., 2010; Headd et al., 2012). These 
restraints can prevent the model from degrading at low resolution when the conformation is 
approximately correct, but should be used with caution because they can result in an incorrect local 
conformation minimum when the model geometry is poor (Richardson et al., 2018). 
Acta Crystallographica Section D   feature articles 
13 
 
– Parallelity restraints: molecules may contain planar atom groups that are approximately parallel to 
each other, such as base pairs and stacking pairs in nucleic acids. Parallelity restraints keep the atom 
groups parallel (Sobolev et al., 2015; Richardson, 2015). 
– Rotamer-specific restraints:  These restraints lock a particular χ-angle configuration of an amino-
acid residue side chain to preserve its valid rotameric state. 
– NCS restraints: If the asymmetric unit contains two or more similar copies of the same molecule, 
torsion- or Cartesian-based NCS restraints can be used. NCS-related atoms can be identified 
automatically or be defined by the user. Torsion-based restraints are generally preferred because they 
require little or no manual intervention to account for common features such as domains that are very 
similar in structure but differ in relative orientation (Headd et al., 2014). 
– Reference model restraints: If the data have low resolution, it can be helpful to use a related 
structure determined at higher resolution as reference model to steer refinement (Headd et al., 2012). 
6.2. X-ray: phenix.refine 
For crystallographic data, refinement is usually performed in reciprocal space, i.e. the parameters of 
the model are changed so that model-derived structure factors match experimental structure factor 
amplitudes or intensities. The refinement target in Phenix can be expressed either as a least-squares or 
as a maximum-likelihood target. Model parameters, which describe the crystal content and its 
properties, are a combination of 1) atomic parameters, such as coordinates, ADPs, occupancies and 
scattering factors and 2) non-atomic parameters, which describe contributions arising from bulk 
solvent, twinning and crystal anisotropy. 
phenix.refine performs crystallographic structure refinement of atomic and non-atomic model 
parameters against experimental data (Afonine et al., 2012) at low to ultra-high resolutions. Each 
refinement run begins with bulk-solvent correction and anisotropic scaling (Afonine et al., 2005, 
2013). The subsequent refinement strategy can be adapted to data resolution. Useful strategies at low 
resolution (or at initial stages) are rigid-body refinement (Afonine et al., 2009), simulated-annealing 
refinement in Cartesian or torsion-angle space (Grosse-Kunstleve et al., 2009) and detection and use 
of NCS (Kleywegt & Jones, 1995). ADP parameterizations include the Translation/Libration/Screw 
(TLS) model for movement of groups treated as rigid (Schomaker & Trueblood, 1968; Urzhumtsev et 
al., 2016; Afonine, Adams et al., 2018) as well as individual isotropic, anisotropic and grouped 
isotropic ADP. At ultra-high resolution (better than 0.7 Å), the interatomic scatterer model can 
account for residual density from bonding effects (Afonine et al., 2007). The program also offers 
occupancy refinement for any user-defined atoms. Water molecules can be placed and updated 
automatically, and improbable side chain rotamers can be replaced. In the later stages of refinement it 
is worthwhile adding hydrogen atoms, since they participate in most inter- and intra-molecular 
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contacts and their presence enables identification of steric clashes and hydrogen bonds. Hydrogen 
atoms can be added at nuclear positions or at electron-cloud-center positions (Deis et al., 2013). 
phenix.refine is designed to be flexible so that multiple refinement strategies can be combined with 
each other and applied to any selected part of the model in a single run. As there are several hundred 
parameters, protocols can be customized for specific needs. The phenix.refine graphical user interface 
(GUI) is integrated with Coot (Emsley et al., 2010) and PyMOL (DeLano, 2002), so that refined 
models and associated maps can be readily displayed and analyzed.  
While phenix.refine is the main crystallographic refinement program of Phenix, the following 
integrated alternatives exist: 
– A recent addition integrates the Amber molecular-mechanics force field (Case et al., 2018) for 
restraints with the functionality of phenix.refine. Amber uses energy based geometry terms and adds 
electrostatics and van der Waals attractive/dispersive interactions. Amber refinement in Phenix has 
been shown to improve model quality, especially sterics and hydrogen bonding at lower resolutions, 
and to reduce overfitting (Moriarty et al., in preparation). 
– “Ensemble refinement” (phenix.ensemble_refinement) combines crystallographic refinement with 
molecular dynamics to produce ensemble models fitted to diffraction data (Burnley et al., 2012). The 
ensemble models can contain ~50-500 individual copies and simultaneously account for anisotropic 
and anharmonic distributions. 
– “DEN refinement” (DEN = Deformable elastic network) uses a restraint network to maintain local 
model geometry while allowing for larger global domain motions over the course of several cycles of 
simulated annealing. The protocol is particularly useful for low resolution diffraction data (Brunger et 
al., 2012). 
–“Rosetta refinement” (phenix.rosetta_refine) integrates the Rosetta methods for conformational 
sampling (DiMaio et al., 2013) with the X-ray targets, ADP refinement and map generation in 
phenix.refine. This tool is useful at low resolution, where it combines a wide radius of convergence 
across distinct local minima with realistic geometry. It can also be used to prepare crystal structures 
for further modelling in Rosetta.  
6.3. Cryo-EM: phenix.real_space_refine 
The outcome of the single-particle cryo-EM reconstruction is a three-dimensional map, so it is natural 
to perform refinement of the model in real-space. Phases are experimentally determined and are not 
improved by the procedure. 
The recently developed tool, phenix.real_space_refine, was specifically designed to perform 
refinements in real-space (Afonine, Poon et al., 2018). The algorithm uses a simplified refinement 
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target function that makes calculations faster, so that optimal data-restraint weights can be identified 
with little runtime cost. In addition to standard restraints on covalent geometry, 
phenix.real_space_refine makes use of secondary-structure, Ramachandran plot and rotamer-spacific 
restraints as well as internal molecular symmetry constraints. The default mode performs gradient-
driven minimization of the entire model, but optimization can also be performed using simulated 
annealing, morphing (Terwilliger et al., 2013), rigid-body refinement and systematic side-chain 
improvement (Oldfield, 2001). As is the case for reciprocal-space refinement, real-space refinement 
should be alternated with validation and manual corrections. The real-space refinement procedure is 
robust and works at resolutions from 1 to 6	Å. 
6.4. Tools for neutron crystallography  
6.4.1. Adding H/D atoms 
Crystals used for neutron diffraction experiments contain H, D or both H and D atoms. If both 
isotopes are present, some sites (labile or exchangeable sites) can be shared by H and D, i.e. some 
molecules have D at a particular site, while the others have H.  
ReadySet (phenix.ready_set) adds H or D atoms to a model file using the REDUCE algorithm (Word, 
Lovell, Richardson et al., 1999). In particular, the tool can add H/D at exchangeable sites of protein 
amino acids and H or D to water molecule O atoms. At labile sites, hydrogen atoms are placed in 
alternative location "A" and the corresponding deuterium atoms are placed in "B".  
6.4.2. Joint refinement in phenix.refine 
Due to fairly prohibitive experimental demands, neutron diffraction data from macromolecules 
typically have low data completeness and a low signal to noise ratio. Furthermore, the model contains 
H (or D) atoms as independent parameters, increasing the number of variables significantly. As an X-
ray structure is usually available before a neutron experiment is conducted, it is possible to refine a 
single model of a macromolecule simultaneously against X-ray and neutron data. This strategy, called 
joint X-ray and neutron refinement (joint XN refinement), ameliorates the data-to-parameters ratio by 
increasing the amount of experimental data used in refinement, leading to more complete and accurate 
models (Coppens, 1967; Orpen et al., 1978; Wlodawer, 1980; Wlodawer & Hendrickson, 1982). 
Macromolecular models can be refined with phenix.refine using neutron data or X-ray and neutron 
data simultaneously (Adams, Mustyakimov et al., 2009; Afonine et al., 2010). The program 
automatically detects exchangeable H/D sites in the model and ensures that the sum of occupancies is 
equal to one. The position of H (or D) atoms can be refined with a ‘riding model’ (Busing & Levy, 
1964; Sheldrick & Schneider, 1997) or individually. All standard tools available for X-ray refinement 
(section 6.2) are also available for refinement using neutron data. 
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7. Validation 
Validation indicates good parts and highlights problems in macromolecular models and should guide 
corrections throughout the structure solution process. In particular, the refinement stage benefits from 
validation: the process consists of cycles of validation, rebuilding (either manual or automated) and 
automated refinement, repeated until a satisfactory model is obtained. As problems are corrected, the 
model quality, refinement behavior and even the density map quality (for X-ray and neutron) all 
improve.  
Validation addresses data, model and model-vs-data quality. This section covers model and model-vs-
data quality as data quality was already described in section 3. There are many well-established 
metrics with new ones being developed to cover emerging needs. Some metrics are global (such as 
Rfree), others are local (such as a Ramachandran outlier), but each local measure is usually also 
collected into a global score (such as the clashscore, Word, Lovell, LaBean et al., 1999). The most 
diagnostic and reliable validation criteria are those not used in the refinement target, providing 
independent direction for rebuilding. 
In Phenix, validation for crystallographic or cryo-EM data and models is performed with the 
respective “Comprehensive validation” GUIs, or on the command line. The underlying principles 
behind model validation are the same for any experimental method. A good model should make 
chemical sense and be consistent with empirical statistics for high-quality prior structures. The most 
useful validation criteria depend on the resolution of the data. Model-vs-data validation depends on 
the type of experimental data and requires that the model explains its own data well. Generally, the 
goal is not zero outliers, but as few outliers as feasible (Richardson, Williams, Hintze et al., 2018). 
Ideally, each outlier should be explainable by reference to its environment (e.g. hydrogen bonding 
and/or steric packing stabilizing a rotamer outlier) and/or by the experimental data. 
7.1. Model validation 
In Phenix, model validation is provided in the “Comprehensive validation” GUI. Overall model 
statistics are presented in a summary chart with local scores as graphic plots and as tables that list the 
outliers on each criterion. Model validation tasks are essentially identical to the MolProbity web 
service (molprobity.biochem.duke.edu) (Chen et al., 2010; Richardson, Williams, Hintze et al., 2018; 
Williams, Headd et al., 2018). 
The “Comprehensive validation” tool uses bond lengths and angle target values for proteins, nucleic 
acids and ligands from the same libraries applied for refinement restraints (section 6.1). 
Conformational, steric and some special-purpose metrics use the algorithms developed for MolProbity 
(Williams, Headd et al., 2018) and implemented in the cctbx (section 9). Cβ deviations diagnose 
sidechain-backbone incompatibility around the Cα tetrahedron (Lovell et al., 2003) except when 
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covalent geometry restraints need to be so tight at low resolution that a Cβ atom cannot deviate from 
ideal even if its position is incorrect.  
Conformational validation relies on MolProbity's smoothed, multi-dimensional distributions for 
dihedral-angle combinations from quality-filtered reference data (Chen et al., 2010; Williams, Headd 
et al., 2018). Ramachandran backbone scores use six φ,ψ distributions that have quite different outlier 
contours: general, Ile/Val, Gly, pre-Pro, trans-Pro and cis-Pro (Read et al., 2011). Figure 8a shows the 
underlying pre-Pro data distribution and 8b the pre-Pro plot for a query model as shown in the 
validation GUI. Sidechain rotamer distributions were recently updated (Hintze et al., 2016). Omega 
distributions flag cis or twisted peptides. RNA ribose pucker outliers are diagnosed by a simple 
relationship between the well-fit 3' phosphate and glycosidic bond direction (Richardson et al., 2008), 
which also enables pucker-specific geometry targets in refinement (Adams et al., 2010). 
Steric validation is accomplished by adding and optimizing hydrogen atoms with REDUCE and 
calculating their all-atom contacts with PROBE (Word, Lovell, Richardson et al., 1999; Word, Lovell, 
LaBean et al., 1999). An overall measure, called clashscore, is the number of serious clashes (non-H-
bond overlap ≥ 0.4 Å) per 1000 atoms. REDUCE can also correct Asn/Gln/His “flips” and suggest 
His protonation. Clashes flag problems at any resolution if they occur, but it is possible that the 
clashscore can be artificially reduced due to tight non-bonded distance restraints. At high resolution, 
clashes flag incompatibilities within each alternate-conformation model or in disordered regions 
where geometry and steric restraints have been down-weighted or removed. 
The CaBLAM analysis (Williams, Headd et al., 2018) was recently developed to validate protein 
backbone conformations in models determined at low resolution (2.5 to 4 Å), where it is difficult to 
determine peptide orientations as carbonyl oxygens cannot be discerned in density maps (this applies 
for crystallography and for cryo-EM). CaBLAM uses virtual Cα dihedrals to determine the local 
chain trace along with a virtual CO dihedral to diagnose where a peptide orientation is incompatible 
with it. CaBLAM outliers are not subject to overfitting, so they provide a less biased quality indicator. 
Most but not all CaBLAM outliers at the 1 % level flag a real problem, which usually requires 
changing the peptide orientation considerably rather than tweaking it across a contour boundary. They 
can often be corrected manually by modifying peptide orientations or by regularizing the local 
secondary structure. 
Several rare but serious problems are now flagged if they occur, such as cis-nonPro peptides which 
are genuine (and typically with a clear structural role) for only one in 3000 residues and have been 
grossly overused especially at low resolution (Croll, 2015; Williams, Videau et al., 2018). Cis-nonPro 
peptides cannot be justified by experimental data at resolutions lower than 2.5 Å and should be 
modeled only if known from other resources (Richardson, Williams, Videau et al., 2018). Hydrogen 
and deuterium atoms are now analyzed if they are present, summarizing relevant properties and 
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flagging issues with H, D or exchanged sites, such as missing atoms, unusual geometry and unlikely 
occupancies. This is of particular use for models determined with neutron diffraction (Liebschner et 
al., 2018). 
In the Phenix GUI, the results from all specific validations are seamlessly integrated with the graphics 
programs Coot and PyMol (Fig. 9). Outliers of any type are listed as a table with clicking on an outlier 
will recenter the graphics window on that atom or residue. If experimental data were supplied, maps 
will be displayed as well. The KiNG Java-based viewer (Chen et al., 2009) set up by 
phenix.kinemage, displays all model validation outliers in 3D to highlight local clusters of outliers 
around single serious problems. Generally, the integration of validation results with graphics 
programs reduces the effort required to fix problems. An extensive guide to the interpretation and use 
of model validation is available from the 2017 CCP4 Study Weekend (Richardson, Williams, Hintze 
et al., 2018). 
7.2. Model vs. data validation 
7.2.1. Comprehensive validation: Crystallography  
Overall agreement between the model and the diffraction data is measured by R-factors, which 
evaluate the difference between observed (Fobs) and calculated (Fmodel) structure factor amplitudes:  
R=Σ| |Fobs|-|Fmodel| |/Σ|Fobs|  (2) 
The Rwork value is calculated on the large subset of the diffraction data used for refinement. For cross-
validation, Rfree is calculated on a subset (typically about 2000 reflections) that are not used in 
refinement (Brünger, 1992). If Rfree increases while Rwork decreases, the model might be incorrectly 
parameterized or the refinement strategy needs to be revised (Kleywegt & Brünger, 1996).  
phenix.refine reports Rwork and Rfree values after refinement; R factor plots show how the values changed 
during the refinement run. The distribution of R factors across resolution shells can be used to pin-
point anomalies such as ice rings, saturated reflections or problems with bulk-solvent modeling.  
While R factors are calculated in reciprocal space, real-space correlation coefficients measure how the 
model fits the density map locally, for example at the chain, residue or atom level. In Phenix 
validation, residues with low real-space correlation coefficients are listed in a table linked to graphics 
programs, allowing recentering on the residue in question to enable analysis and correction. This is 
useful because the correlation may be sometimes misleading. 
The Polygon tool combines six diverse measures (average ADP, rmsd bonds and angles, clashscore, 
Rwork and Rfree) to visualize the refinement outcome in radial, one-dimensional histograms (Urzhumtseva 
et al., 2009). Lines connecting the scores form a hexagonal polygon that should be small and 
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approximately symmetric. This is similar to the wwPDB slider graphic5 that conveys model quality at 
a glance. 
7.2.2. Comprehensive validation: Cryo-EM 
While validation methods in crystallography have had decades to mature, cryo-EM only recently 
evolved into a routine technique for near-atomic resolution models (Kühlbrandt, 2014). The search for 
appropriate metrics to assess model and model-to-data fit is therefore still ongoing (Afonine, Klaholz 
et al., 2018). One measure of agreement between a model and a map is the model-map correlation 
coefficient (map CC) (Brändén & Jones, 1990; Jones et al., 1991). In reciprocal space, model-vs-data 
agreement is assessed by curves of the Fourier shell correlation (FSC) as a function of resolution. The 
map-model FSC is the correlation between the Fourier coefficients computed by Fourier 
transformation of the 3D reconstruction and of a model-based map (Rosenthal & Henderson, 2003).  
The Phenix “Comprehensive validation” tool (Fig. 8) for cryo-EM reports newly developed model 
and map-to-model quality indicators (Afonine, Klaholz et al., 2018), such as CaBLAM outliers, the 
CC using the entire map (CCbox), the CC within a mask (CCmask) and the map-model FSC curve. Plots of 
average CCs per chain and per residue help identify problematic regions of the macromolecule. 
The EMRinger (phenix.emringer) score quantifies how well the model backbone puts side chains in 
density peaks that are consistent with rotameric conformations (Barad et al., 2015). 
8. Other tools 
8.1. X-ray 
8.1.1. Electron density maps  
Electron density maps are routinely used to guide manual model building of crystallographic 
structures. Below is a selection of tools for map calculations in Phenix. The Phenix documentation 
includes a more complete list (www.phenix-online.org/documentation/). 
– “Polder maps” (phenix.polder) uncover weak difference densities by locally excluding bulk solvent 
(Liebschner et al., 2017). They are useful for ligands and residues protruding into the solvent area. 
– “Composite OMIT maps” (phenix.composite_omit_maps) are generated by combining omit maps of 
specific regions to obtain a map covering the entire contents of the unit cell (Brünger et al., 1998). 
This map is relatively bias-free without severely compromising phase quality. 
                                                   
5 https://www.wwpdb.org/validation/2017/XrayValidationReportHelp#overall_quality 
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– “Feature-enhanced maps” (FEM, phenix.feature_enhanced_map) modify a 2mFobs-DFmodel sigmaA-
weighted map so that weak signals are strengthened while model bias and noise are reduced (Afonine 
et al., 2015).  
New metrics to compare crystallographic contour maps are available in the tool “Map Sigma Level 
Comparison” (phenix.map_comparison)(Urzhumtsev et al., 2014). 
8.1.2. Structure comparison 
It is common to study near-identical protein structures, such as mutants, proteins with different 
ligands or NCS-related copies. Oftentimes, it is useful to compare the structures to find differences 
and similarities. 
The “Structure comparison” tool (Moriarty et al., 2018) validates and analyzes similar protein models 
(> 80 % sequence identity). The GUI displays validation outliers and conformational differences 
between chains in a table, linked to graphics windows (Coot and PyMOL). Analyses include ligands, 
persistent ions and water molecules, rotamers, Ramachandran angles, missing atoms, secondary 
structure, water locations, omega angles and ADPs. The extracted chains and electron density maps 
can be superimposed onto a common frame of reference. The chains may subsequently be edited in 
Coot to ensure consistency and/or fix errors and recovered in their original orientations for further 
refinement and rebuilding. 
8.1.3. Ligand fitting 
The goal of a crystallographic study is often to understand the interaction of a small-molecule ligand 
with a macromolecule. It is also common to discover density for an unanticipated small molecule. In 
both cases, it is necessary to fit the ligand into the electron density to complete the atomic model.  
Phenix has several tools to investigate ligands: 
– “LigandFit” (phenix.ligand_fit) identifies difference density peaks in a map and tries to place a user 
defined ligand in the density (Terwilliger et al., 2006, 2007). 
– “Guided ligand replacement” (phenix.guided_ligand_replacement) uses prior knowledge about 
ligand binding in a protein to assist the fitting of a similar ligand into the same or a similar protein 
(Klei et al., 2014). This tool helps study a series of compounds for the same or related 
macromolecular targets. 
– “Ligand identification” (phenix.ligand_identification) analyzes difference density peaks to reveal 
which ligand is likely to be present (Terwilliger et al., 2006, 2007). The tool uses a library of 180 
most frequently observed ligands in the PDB and ranks each molecule by density fit and chemical 
interactions with the macromolecule. 
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8.2. Using other programs within Phenix 
Several programs from external developers can be executed in Phenix. Most require separate 
installation. 
– MR-Rosetta (phenix.mr_rosetta) uses homology modeling in the Rosetta program to improve a 
model before and/or after MR (DiMaio et al., 2011; Terwilliger et al., 2012). Once a potential 
solution is obtained, Rosetta fills in missing sections and rebuilds the model to improve the fit to the 
electron density map and the phases for map interpretation or automated model building. This 
approach is helpful in cases where the MR model differs greatly from the target.  
– ERRASER (Chou et al., 2013) improves RNA backbone conformations by combining the 
MolProbity clash analysis, Phenix refinement and a pruned enumeration and optimization in Rosetta. 
– Conventional restraints may not capture the influences of intermolecular covalent and non-bonded 
interactions, metal coordination or solvation. The semiempirical quantum mechanics engine DivCon 
is integrated into phenix.refine to create gradients for a region of interest (Borbulevych et al., 2014). 
– CryoFit uses molecular dynamics to perform flexible fitting of a model to a cryo-EM map 
(Kirmizialtin et al., 2015; Kim et al., 2019). The approach produces a new conformational model with 
optimized atomic coordinates and preserved stereochemistry and secondary structure.  
– Quantum refinement (Q|R) is a method to refine macromolecular models with restraints derived 
from quantum chemistry instead of library-based restraints (Zheng, Moriarty et al., 2017; Zheng, 
Reimers et al., 2017). The Q|R source code (https://github.com/qrefine/qr-core) uses the cctbx 
(section 9.1) to construct a refinement protocol resembling phenix.refine.  
- Isolde (Croll, 2018) is a plugin to UCSF ChimeraX (Goddard et al., 2018) for improving low-
resolution cryoEM or crystal structures. It performs interactively guided simulation with molecular-
dynamics flexible fitting against a map and real-time validation; it will soon be possible to launch 
from the Phenix GUI. 
- Cryo-EM model building with Pathwalker (Baker et al., 2012; Chen et al., 2016) will soon be 
available within Phenix. Pathwalker can construct protein backbone models directly from near-atomic 
resolution cryo-EM density maps using a modified approach to Traveling Salesman Problem solvers. 
When coupled with Phenix tools, such as phenix.pulchra (Rotkiewicz & Skolnick, 2008) and real-
space refinement, complete atomistic models can be generated within a few minutes for individual 
proteins or complexes.  
8.3. Tools for model deposition 
Several tools are available to facilitate deposition process of macromolecular structures: 
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- “Generate table 1 for journal” (phenix.table_one) is a tool for generating the standard table of 
crystallographic statistics required by most scientific journals for structure solutions. It summarizes 
validation statistics and calculates merging statistics for crystallographic data. For cryo-EM structures, 
the “Comprehensive validation (CryoEM)” GUI has a button to generate a similar table containing the 
model validation statistics as well as map resolution estimates. 
- “Prepare model for PDB deposition” (mmtbx.prepare_pdb_deposition) adds the sequence 
information to the model file. In particular, the tool creates model files in PDBx/mmCIF format, 
which is mandatory for crystallographic depositions to the PDB since July 1st 2019 (Adams et al., 
2019). 
- “Get PDB validation report” (phenix.get_pdb_validation_report) retrieves the validation report 
from the wwPDB through their web interface. By providing the model and optional data in mmCIF 
format, the validation report can help users identify problems before starting the deposition process. 
9. Infrastructure 
9.1. Architecture 
Phenix is built on the Computational Crystallography Toolbox (cctbx), which is an open-source 
library (https://github.com/cctbx/cctbx_project) of reusable software components for macromolecular 
structure determination (Grosse-Kunstleve et al., 2002). The cctbx components are written both in a 
compiled language (C++) and a flexible scripting language (Python, Lutz & Ascher, 1999). This 
approach is very efficient because high-level algorithms (such as refinement protocols) can be rapidly 
developed in the scripting language while computationally intensive algorithms can be implemented 
in the compiled language. The Boost.Python Library (http://www.boost.org/) is used to expose the 
C++ interfaces, classes and functions to Python (Grosse-Kunstleve & Abrahams, 2003). 
The GUI is scripted through Python and produces a ‘native’ look6 on each operating system. The 
current Phenix release (version 1.16) includes GUIs for all major programs. Embedded graphs are 
computed with the free matplotlib Python library (Hunter, 2007). A simple 3D graphics viewer can be 
used to display the molecule or to pick atom selections interactively.  
9.2. Documentation 
The Phenix GUI provides more than 175 tools, with even more programs available on the command 
line (~500). The extensive online manual covers about 180 separate HTML pages and describes GUI 
and command line versions of individual programs and includes tutorials and FAQs. The Phenix 
Tutorials Youtube channel (https://www.youtube.com/c/phenixtutorials, Fig. 10) currently provides 29 
                                                   
6 The application takes on the convention, gestures and aesthetics of their operating system. 
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tutorial videos. Each video introduces a Phenix tool, summarizes the input files and parameters, 
explains how to run the program and discusses the results.  
10. Conclusion 
The Phenix software for macromolecular structure determination handles data from three 
experimental methods: cryo-EM, X-ray diffraction and neutron diffraction. All steps in the structure 
solution process are addressed by programs that are tailored for the type of experimental data, but 
share algorithms where appropriate. Procedures are automated to minimize repetitive and time-
consuming manual tasks as far as feasible. For the future, the improvement of automated model 
building, refinement and validation at low resolution (worse than 3 Å) remains a priority; another area 
of development to help the structural biology community is the automated identification, fitting and 
refinement of ligands, ions and water. 
Many challenging opportunities still exist in crystallography and cryo-EM owing to advances in light 
sources and instrumentation making it possible to go beyond structure determination by single crystal 
diffraction and single particle cryo-EM. For example, free electron lasers (FELs) and serial 
synchrotron crystallography (Chapman et al., 2011; Rossmann, 2014; Diederichs & Wang, 2017; 
Standfuss & Spence, 2017; Schlichting, 2015) have opened up new approaches to studying the 
dynamics of macromolecules. Therefore, methods are needed to extract models of molecular motion 
from time resolved diffraction experiments. Diffuse X-ray scattering (Wall et al., 2014, 2018) can 
also reveal molecular motions and lattice disorder, but methods to exploit the information contained in 
diffuse scatter are still scarce. Micro-electron diffraction (MicroED) (Liu et al., 2017; Gruene et al., 
2018; Jones et al., 2018; Nannenga & Gonen, 2018) is an emerging technique to determine high-
resolution structures of macromolecules. Current procedures for diffraction data will require fine-
tuning to treat MicroED data adequately. Similarly, while cryo-EM is typically currently applied to 
large molecules and complexes, it is becoming increasingly possible to look at smaller molecules 
because of improvements in instrumentation and data processing. Furthermore, the use of focused 
refinement of cryo-EM data (von Loeffelholz et al., 2017; Natchiar et al., 2017) can generate much 
improved local reconstructions, but it remains to be seen how these can be best combined for model 
generation and subsequent model refinement. Finally, cryo-tomography, which is a type of electron 
microscopy that can probe entire cells and thus enable visualization of molecules in situ, nowadays 
produces reconstructions better than 10 Å, in some cases significantly better. There will be an 
increasing need to accurately and effectively combine such lower resolution information with results 
from high-resolution crystallographic or cryo-EM experiments.  
 
 
Acta Crystallographica Section D   feature articles 
24 
 
 
 
 
 
 
 
 
 
Figure 1 Experimental methods used to determine macromolecular structures that are deposited in 
the PDB. The predominant method is X-ray diffraction, followed by Nuclear Magnetic Resonance 
(NMR), cryo-EM and neutron diffraction.  
 
 
Figure 2 Annual cryo-EM model deposition now outnumbers X-ray model deposition in the 
resolution range 3.5 - 5 Å. 
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Figure 3 Since 2015, cryo-EM depositions account for the majority of large macromolecular 
structures. 
 
 
Figure 4 The structure solution steps for X-ray/neutron crystallography and cryo-EM have nuances 
for each technique, but the overall workflow is similar. Color code: cryo-EM = grey, X-ray 
crystallography = green, neutron crystallography = red. As neutron diffraction experiments are 
typically performed with samples whose structure is known, the phasing, density modification and 
model-building steps are not part of the workflow. 
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Figure 5 The primary tools for X-ray crystallography in Phenix. 
 
Figure 6 The primary tools for cryo-EM in Phenix.  
 
 
Figure 7 Cryo-EM maps deposited per year for different resolution ranges: better than 3 Å, 3 - 4 Å, 
4 - 5 Å, worse than 5 Å. 
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Figure 8 Ramachandran φ,ψ plots for the pre-Pro case. a) The reference distribution of 60,000 well-
determined pre-Pro residues, with contours that enclose the favored 98% of the data (thin green) and 
that exclude the outliers (heavy green). b) A pre-Pro Ramachandran plot in the Phenix GUI for a 
query structure, showing two labeled outliers in red. Note that pre-Pro is very different from a 
general-case Ramachandran plot. 
 
 
Figure 9 Screenshots of the cryo-EM “Comprehensive validation” tool and a Coot window. 
Clicking on the item in the table of cis/twisted peptides (highlighted in grey) recenters the Coot 
window on that peptide. 
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Figure 10 The videos on the Phenix tutorials YouTube channel cover main Phenix programs, 
refinement strategies and lectures. 
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